VAFP
ITCI
Vahanian & Associates Financial Planning’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | $710K | Sell |
9,917
-5,300
| -35% | -$380K | 2.81% | 9 |
|
2023
Q3 | $793K | Hold |
15,217
| – | – | 2.55% | 9 |
|
2023
Q2 | $964K | Sell |
15,217
-915
| -6% | -$57.9K | 3.05% | 8 |
|
2023
Q1 | $874K | Sell |
16,132
-2,460
| -13% | -$133K | 2.42% | 9 |
|
2022
Q4 | $984K | Sell |
18,592
-8,200
| -31% | -$434K | 3.22% | 7 |
|
2022
Q3 | $1.25M | Sell |
26,792
-10,900
| -29% | -$507K | 4.29% | 4 |
|
2022
Q2 | $2.15M | Sell |
37,692
-7,841
| -17% | -$447K | 9.25% | 2 |
|
2022
Q1 | $2.79M | Sell |
45,533
-26,209
| -37% | -$1.6M | 6.44% | 3 |
|
2021
Q4 | $3.76M | Buy |
+71,742
| New | +$3.76M | 3.03% | 6 |
|